WO2001062668A3 - Sulfur containing compounds - Google Patents

Sulfur containing compounds Download PDF

Info

Publication number
WO2001062668A3
WO2001062668A3 PCT/CA2001/000234 CA0100234W WO0162668A3 WO 2001062668 A3 WO2001062668 A3 WO 2001062668A3 CA 0100234 W CA0100234 W CA 0100234W WO 0162668 A3 WO0162668 A3 WO 0162668A3
Authority
WO
WIPO (PCT)
Prior art keywords
containing compounds
sulfur containing
cells
antifungals
efficient
Prior art date
Application number
PCT/CA2001/000234
Other languages
French (fr)
Other versions
WO2001062668A2 (en
Inventor
Richard Francis Langler
Felix J Baerlocker
Linda Z Penn
Original Assignee
Univ Health Network
Richard Francis Langler
Felix J Baerlocker
Linda Z Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002299247A external-priority patent/CA2299247A1/en
Application filed by Univ Health Network, Richard Francis Langler, Felix J Baerlocker, Linda Z Penn filed Critical Univ Health Network
Priority to CA002402114A priority Critical patent/CA2402114A1/en
Priority to JP2001561685A priority patent/JP2003523983A/en
Priority to AU2001237173A priority patent/AU2001237173A1/en
Priority to EP01909377A priority patent/EP1259482A2/en
Priority to US10/204,944 priority patent/US20030220524A1/en
Publication of WO2001062668A2 publication Critical patent/WO2001062668A2/en
Publication of WO2001062668A3 publication Critical patent/WO2001062668A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02Sulfinic acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

This invention is directed to novel and known sulfur containing compounds and pharmaceutically acceptable salts thereof that have utility as antifungals and as antiproliferative agents against mammalian cells, in particular cancer cells and most particularly leukemia-derived cells. The invention provides a method for synthesizing certain of the sulfur containing compounds that is more efficient than previously known methods.
PCT/CA2001/000234 2000-02-25 2001-02-26 Sulfur containing compounds WO2001062668A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002402114A CA2402114A1 (en) 2000-02-25 2001-02-26 Sulfur containing compounds
JP2001561685A JP2003523983A (en) 2000-02-25 2001-02-26 Sulfur-containing compounds
AU2001237173A AU2001237173A1 (en) 2000-02-25 2001-02-26 Sulfur containing compounds
EP01909377A EP1259482A2 (en) 2000-02-25 2001-02-26 Sulfur containing compounds
US10/204,944 US20030220524A1 (en) 2000-02-25 2001-02-26 Sulfur containing compounds

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18518900P 2000-02-25 2000-02-25
US60/185,189 2000-02-25
CA002299247A CA2299247A1 (en) 2000-02-25 2000-02-25 Sulfur containing compounds
CA2,299,247 2000-02-25

Publications (2)

Publication Number Publication Date
WO2001062668A2 WO2001062668A2 (en) 2001-08-30
WO2001062668A3 true WO2001062668A3 (en) 2002-05-16

Family

ID=25681563

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2001/000234 WO2001062668A2 (en) 2000-02-25 2001-02-26 Sulfur containing compounds

Country Status (4)

Country Link
EP (1) EP1259482A2 (en)
JP (1) JP2003523983A (en)
AU (1) AU2001237173A1 (en)
WO (1) WO2001062668A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2571800A1 (en) * 2005-12-23 2007-06-23 Canadian Blood Services Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction
WO2013124441A1 (en) * 2012-02-23 2013-08-29 Pancosma S.A. Use of dialkyl-thiosulfinate and/or thiosulfonate to improve the resistance of an animal infected by a pathogen
US20150238579A1 (en) * 2014-02-26 2015-08-27 Investfood, LLC Methods for assembling a product for modulating an immunomodulatory response in humans
EP4412457A1 (en) * 2021-10-08 2024-08-14 Crop Health Vision B.V. Organosulfur compounds as plant biostimulants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643994A (en) * 1984-12-17 1987-02-17 The Research Foundation Of State University Of New York Novel organic trithio oxides and method for the preparation thereof
US5583235A (en) * 1994-03-11 1996-12-10 Shaman Pharmaceuticals, Inc. Preparation of symmetrical and unsymmetrical 3,6-disubstituted-1,2-dithiins having antifungal activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643994A (en) * 1984-12-17 1987-02-17 The Research Foundation Of State University Of New York Novel organic trithio oxides and method for the preparation thereof
US5583235A (en) * 1994-03-11 1996-12-10 Shaman Pharmaceuticals, Inc. Preparation of symmetrical and unsymmetrical 3,6-disubstituted-1,2-dithiins having antifungal activity

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BAERLOCHER F J ET AL: "STRUCTURE-ACTIVITY RELATIONSHIPS FOR SELECTED SULFUR-RICH ANTIFUNGAL COMPOUNDS", AUSTRALIAN JOURNAL OF CHEMISTRY, XX, XX, vol. 52, 1999, pages 167 - 172, XP001028517, ISSN: 0004-9425 *
BECKWITH, A L J ET AL, TETRAHEDRON., vol. 39, no. 23, 1983, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM., NL, pages 3995 - 4002, ISSN: 0040-4020 *
BLOCK ET AL, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., vol. 95, 1973, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC., US, pages 5048, ISSN: 0002-7863 *
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002180002, Database accession no. 4988442 *
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002180003, Database accession no. 2041820 *
F J BAERLOCHER ET AL: "New and more potent antifungal disulfides", AUSTRALIAN JOURNAL OF CHEMISTRY., vol. 53, 2000, pages 1 - 5, XP001030010, ISSN: 0004-9425 *

Also Published As

Publication number Publication date
EP1259482A2 (en) 2002-11-27
JP2003523983A (en) 2003-08-12
AU2001237173A1 (en) 2001-09-03
WO2001062668A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
CA2412708A1 (en) Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
AU2002366644A1 (en) Method for administering birb 796 bs
AU3764901A (en) Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
AP2001002319A0 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors.
WO2004007679A3 (en) Dendritic cell pontentiation
AU2002218140A1 (en) Beam-shaping method
AU2003242146A1 (en) Method of storing hydrogen, hydrogen inclusion compound and process for producing the same
YU19499A (en) Benzonaphthyridines as bronchial therapeutics
MXPA02004556A (en) Solutions containing epinastine.
MXPA03005505A (en) Modafinil compound and cyclodextrin mixtures.
AU5915100A (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
PL343176A1 (en) Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines
WO2002003974A3 (en) Composition comprising folic acid and zinc for improving male fertility
AU2002249779A1 (en) Method to treat hemophilia
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
EP0799827A4 (en) Acrylamide derivatives and process for producing the same
WO2001062668A3 (en) Sulfur containing compounds
ZA985781B (en) Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof.
AU2420001A (en) Methods and compositions for the treatment of pain
AU8631698A (en) A process for the preparation of tetraazamacrocycles
AU2566101A (en) Compounds and methods for the treatment of pain
AU2844799A (en) Stable small sized particle water-in-water emulsions, synthesis method and application as thickening agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2001 561685

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2402114

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001909377

Country of ref document: EP

Ref document number: 2001237173

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2001909377

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10204944

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001909377

Country of ref document: EP